Foundations Investment Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,954
Closed -$282K 397
2022
Q1
$282K Sell
7,954
-132
-2% -$5.14K 0.01% 282
2021
Q4
$341K Buy
8,086
+4,325
+115% +$226K 0.01% 254
2021
Q3
$246K Buy
3,761
+443
+13% +$33.7K 0.01% 275
2021
Q2
$290K Buy
+3,318
New +$264K 0.01% 240

Other funds holding CDNA

Foundations Investment Advisors's CDNA Position: Q2 2022 in Review

Foundations Investment Advisors sold out of CareDx (CDNA) in Q2 2022, closing a stake of 7,954 shares — an estimated $282K sold.

Foundations Investment Advisors first reported a position in CDNA in Q2 2021 and held it in 4 quarters. The position peaked at $341K in Q4 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Foundations Investment Advisors reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Foundations Investment Advisors sold 7,954 CareDx shares in Q2 2022, an estimated $282K.
  • Foundations Investment Advisors first reported a position in CareDx in Q2 2021 and held it in 4 quarters.
  • Foundations Investment Advisors's CareDx position peaked at $341K in Q4 2021.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Foundations Investment Advisors's 13F filing for Q2 2022, filed 8 Jul 2022.